相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Vascularization of Patient-Derived Tumoroid from Non-Small-Cell Lung Cancer and Its Microenvironment
Joseph Seitlinger et al.
BIOMEDICINES (2022)
Laser-Mediated antibacterial effects of Few- and Multi-Layer Ti3C2Tx MXenes
Andreas Rosenkranz et al.
APPLIED SURFACE SCIENCE (2021)
Patient-derived organoid (PDO) platforms to facilitate clinical decision making
Lisa Liu et al.
JOURNAL OF TRANSLATIONAL MEDICINE (2021)
Molecular profiling of long-term responders to immune checkpoint inhibitors in advanced non-small cell lung cancer
Joan Frigola et al.
MOLECULAR ONCOLOGY (2021)
Progress towards non-small-cell lung cancer models that represent clinical evolutionary trajectories
Robert E. Hynds et al.
OPEN BIOLOGY (2021)
Tumor Hypoxia Regulates Immune Escape/Invasion: Influence on Angiogenesis and Potential Impact of Hypoxic Biomarkers on Cancer Therapies
Raefa Abou Khouzam et al.
FRONTIERS IN IMMUNOLOGY (2021)
3D Culture Systems for Exploring Cancer Immunology
Allison A. Fitzgerald et al.
CANCERS (2021)
FDA Approval Summary: Nivolumab with Ipilimumab and Chemotherapy for Metastatic Non-small Cell Lung Cancer, A Collaborative Project Orbis Review
Paz J. Vellanki et al.
CLINICAL CANCER RESEARCH (2021)
Cemiplimab monotherapy for first-line treatment of advanced non-small-cell lung cancer with PD-L1 of at least 50%: a multicentre, open-label, global, phase 3, randomised, controlled trial
Ahmet Sezer et al.
LANCET (2021)
Genetic Determinants of EGFR-Driven Lung Cancer Growth and Therapeutic Response In Vivo
Giorgia Foggetti et al.
CANCER DISCOVERY (2021)
Organoid and Spheroid Tumor Models: Techniques and Applications
Sreenivasulu Gunti et al.
CANCERS (2021)
Lung carcinoma spheroids embedded in a microfluidic platform
Ece Yildiz-Ozturk et al.
CYTOTECHNOLOGY (2021)
Primary Lung Cancer Organoids for Personalized Medicine-Are They Ready for Clinical Use?
Raphael S. Werner et al.
CANCERS (2021)
Lung cancer organoids analyzed on microwell arrays predict drug responses of patients within a week
Yawei Hu et al.
NATURE COMMUNICATIONS (2021)
Evaluating the transcriptional fidelity of cancer models
Da Peng et al.
GENOME MEDICINE (2021)
Microvascularized tumor organoids-on-chips: advancing preclinical drug screening with pathophysiological relevance
Jungeun Lim et al.
NANO CONVERGENCE (2021)
Patient-derived organoids as a predictive biomarker for treatment response in cancer patients
G. Emerens Wensink et al.
NPJ PRECISION ONCOLOGY (2021)
Clinical application of a lung cancer organoid (tumoroid) culture system
Etsuko Yokota et al.
NPJ PRECISION ONCOLOGY (2021)
Immunocompetent cancer-on-chip models to assess immuno-oncology therapy
Tengku Ibrahim Maulana et al.
ADVANCED DRUG DELIVERY REVIEWS (2021)
Transcriptomic analysis of tumor tissues and organoids reveals the crucial genes regulating the proliferation of lung adenocarcinoma
Xiao Ma et al.
JOURNAL OF TRANSLATIONAL MEDICINE (2021)
Cancer models in preclinical research: A chronicle review of advancement in effective cancer research
Humna Sajjad et al.
ANIMAL MODELS AND EXPERIMENTAL MEDICINE (2021)
3D In Vitro Model (R)evolution: Unveiling Tumor-Stroma Interactions
Joao Rodrigues et al.
TRENDS IN CANCER (2021)
A microfluidic cathodic photoelectrochemical biosensor chip for the targeted detection of cytokeratin 19 fragments 21-1
Jinhui Feng et al.
LAB ON A CHIP (2021)
In-vitro photothermal therapy using plant extract polyphenols functionalized graphene sheets for treatment of lung cancer
Chunmei Wang et al.
JOURNAL OF PHOTOCHEMISTRY AND PHOTOBIOLOGY B-BIOLOGY (2020)
Organoid Cultures as Preclinical Models of Non-Small Cell Lung Cancer
Ruoshi Shi et al.
CLINICAL CANCER RESEARCH (2020)
Model of Patient-Specific Immune-Enhanced Organoids for Immunotherapy Screening: Feasibility Study
Konstantinos Votanopoulos et al.
ANNALS OF SURGICAL ONCOLOGY (2020)
Patient-derived explants (PDEs) as a powerful preclinical platform for anti-cancer drug and biomarker discovery
Ian R. Powley et al.
BRITISH JOURNAL OF CANCER (2020)
Drug Sensitivity and Allele Specificity of First-Line Osimertinib Resistance EGFR Mutations
Jacqueline H. Starrett et al.
CANCER RESEARCH (2020)
Microphysiological Systems: A Pathologist's Perspective
Radhakrishna Sura et al.
VETERINARY PATHOLOGY (2020)
Challenges in Establishing Pure Lung Cancer Organoids Limit Their Utility for Personalized Medicine
Krijn K. Dijkstra et al.
CELL REPORTS (2020)
Adjuvant and Neoadjuvant Immunotherapy in Non - small Cell Lung Cancer
Stephen R. Broderick
THORACIC SURGERY CLINICS (2020)
Targeted Therapies and Biomarkers in Small Cell Lung Cancer
Hirokazu Taniguchi et al.
FRONTIERS IN ONCOLOGY (2020)
Patients Lung Derived Tumoroids (PLDTs) to model therapeutic response
Frederic Delom et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH (2020)
Current concepts in tumour-derived organoids
Ross J. Porter et al.
BRITISH JOURNAL OF CANCER (2020)
A Review About Pembrolizumab in First-Line Treatment of Advanced NSCLC: Focus on KEYNOTE Studies
Jialin Qu et al.
CANCER MANAGEMENT AND RESEARCH (2020)
Human Lung Adenocarcinoma-Derived Organoid Models for Drug Screening
Zhichao Li et al.
ISCIENCE (2020)
Development of syngeneic murine cell lines for use in immunocompetent orthotopic lung cancer models
Kyle Nolan et al.
CANCER CELL INTERNATIONAL (2020)
miR-335-5p Regulates Cell Cycle and Metastasis in Lung Adenocarcinoma by Targeting CCNB2
Xiyong Wang et al.
ONCOTARGETS AND THERAPY (2020)
Genomic characteristics and drug screening among organoids derived fromnon-small celllung cancer patients
Jing-Hua Chen et al.
THORACIC CANCER (2020)
Atezolizumab for First-Line Treatment of PD-L1-Selected Patients with NSCLC
Roy S. Herbst et al.
NEW ENGLAND JOURNAL OF MEDICINE (2020)
Automated microfluidic platform for dynamic and combinatorial drug screening of tumor organoids
Brooke Schuster et al.
NATURE COMMUNICATIONS (2020)
Organoids in Translational Oncology
Marco Tatullo et al.
JOURNAL OF CLINICAL MEDICINE (2020)
3D Tumor Models and Their Use for the Testing of Immunotherapies
Nicolas Boucherit et al.
FRONTIERS IN IMMUNOLOGY (2020)
Proteomic Reveals Reasons for Acquired Drug Resistance in Lung Cancer Derived Brain Metastasis Based on a Newly Established Multi-Organ Microfluidic Chip Model
Mingxin Xu et al.
FRONTIERS IN BIOENGINEERING AND BIOTECHNOLOGY (2020)
Patient-derived organoids of non-small cells lung cancer and their application for drug screening
Y. F. Li et al.
NEOPLASMA (2020)
Best Practices Recommendations for Diagnostic Immunohistochemistry in Lung Cancer
Yasushi Yatabe et al.
JOURNAL OF THORACIC ONCOLOGY (2019)
Multi-omic measurements of heterogeneity in HeLa cells across laboratories
Yansheng Liu et al.
NATURE BIOTECHNOLOGY (2019)
Lung Cancer Screening, towards a Multidimensional Approach: Why and How?
Jonathan Benzaquen et al.
CANCERS (2019)
Immune checkpoint inhibitors for patients with advanced lung cancer and oncogenic driver alterations: results from the IMMUNOTARGET registry
J. Mazieres et al.
ANNALS OF ONCOLOGY (2019)
Cancer drug development: The missing links
Ajaikumar B. Kunnumakkara et al.
EXPERIMENTAL BIOLOGY AND MEDICINE (2019)
An In Vitro System for Evaluating Molecular Targeted Drugs Using Lung Patient-Derived Tumor Organoids
Nobuhiko Takahashi et al.
CELLS (2019)
New designs in early clinical drug development
A. Mansinho et al.
ANNALS OF ONCOLOGY (2019)
Non-Small Cell Lung Cancer: Epidemiology, Screening, Diagnosis, and Treatment
Narjust Duma et al.
MAYO CLINIC PROCEEDINGS (2019)
Prevalence of PD-L1 Expression Rates in Different NSCLC Specimens
M. Holmes et al.
JOURNAL OF THORACIC ONCOLOGY (2019)
Patient-derived lung cancer organoids as in vitro cancer models for therapeutic screening
Minsuh Kim et al.
NATURE COMMUNICATIONS (2019)
SEOM clinical guidelines for the treatment of non-small cell lung cancer (2018)
M. Majem et al.
CLINICAL & TRANSLATIONAL ONCOLOGY (2019)
Long-term expanding human airway organoids for disease modeling
Norman Sachs et al.
EMBO JOURNAL (2019)
Ex vivo lung cancer spheroids resemble treatment response of a patient with NSCLC to chemotherapy and immunotherapy: case report and translational study
Raimondo Di Liello et al.
ESMO OPEN (2019)
The lung microenvironment: an important regulator of tumour growth and metastasis
Nasser K. Altorki et al.
NATURE REVIEWS CANCER (2019)
A one-stop microfluidic-based lung cancer organoid culture platform for testing drug sensitivity
Da Jung Jung et al.
LAB ON A CHIP (2019)
Genome, transcriptome and proteome: the rise of omics data and their integration in biomedical sciences
Claudia Manzoni et al.
BRIEFINGS IN BIOINFORMATICS (2018)
Mechanisms of resistance to immune checkpoint inhibitors
Russell W. Jenkins et al.
BRITISH JOURNAL OF CANCER (2018)
Cancer Statistics, 2018
Rebecca L. Siegel et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2018)
ADAURA: Phase III, Double-blind, Randomized Study of Osimertinib Versus Placebo in EGFR Mutation-positive Early-stage NSCLC After Complete Surgical Resection
Yi-Long Wu et al.
CLINICAL LUNG CANCER (2018)
Pembrolizumab plus Chemotherapy in Metastatic Non-Small-Cell Lung Cancer
L. Gandhi et al.
NEW ENGLAND JOURNAL OF MEDICINE (2018)
Establishment of patient-derived tumor spheroids for non-small cell lung cancer
Zengli Zhang et al.
PLOS ONE (2018)
Generation of Tumor-Reactive T Cells by Co-culture of Peripheral Blood Lymphocytes and Tumor Organoids
Krijn K. Dijkstra et al.
CELL (2018)
Genetic and transcriptional evolution alters cancer cell line drug response
Uri Ben-David et al.
NATURE (2018)
The biology and management of non-small cell lung cancer
Roy S. Herbst et al.
NATURE (2018)
Role of immune-checkpoint inhibitors in lung cancer
Prantesh Jain et al.
THERAPEUTIC ADVANCES IN RESPIRATORY DISEASE (2018)
Molecular heterogeneity of non-small cell lung carcinoma patient-derived xenografts closely reflect their primary tumors
Dennis Wang et al.
INTERNATIONAL JOURNAL OF CANCER (2017)
FDA Approval Summary: Pembrolizumab for Treatment of Metastatic Non-Small Cell Lung Cancer: First-Line Therapy and Beyond
Lee Pai-Scherf et al.
ONCOLOGIST (2017)
Application of 3D tumoroid systems to define immune and cytotoxic therapeutic responses based on tumoroid and tissue slice culture molecular signatures
Niklas K. Finnberg et al.
ONCOTARGET (2017)
Primary Patient-Derived Cancer Cells and Their Potential for Personalized Cancer Patient Care
David P. Kodack et al.
CELL REPORTS (2017)
Human Organ Chip Models Recapitulate Orthotopic Lung Cancer Growth, Therapeutic Responses, and Tumor Dormancy In Vitro
Bryan A. Hassell et al.
CELL REPORTS (2017)
Immune-Related Adverse Events Associated with Anti-PD-1/PD-L1 Treatment for Malignancies: A Meta-Analysis
Peng-Fei Wang et al.
FRONTIERS IN PHARMACOLOGY (2017)
Drug Development for Breast, Colorectal, and Non-Small Cell Lung Cancers From 1979 to 2014
Nancy A. Nixon et al.
CANCER (2017)
Microfluidic technologies for anticancer drug studies
Karolina P. Valente et al.
DRUG DISCOVERY TODAY (2017)
Tumor Organoids as a Pre-clinical Cancer Model for Drug Discovery
Fleur Weeber et al.
CELL CHEMICAL BIOLOGY (2017)
The Role of Tumor-Infiltrating Lymphocytes in Development, Progression, and Prognosis of Non-Small Cell Lung Cancer
Roy M. Bremnes et al.
JOURNAL OF THORACIC ONCOLOGY (2016)
FDA Approval Summary: Nivolumab for the Treatment of Metastatic Non-Small Cell Lung Cancer With Progression On or After Platinum-Based Chemotherapy
Dickran Kazandjian et al.
ONCOLOGIST (2016)
Biomarkers for the Clinical Use of PD-1/PD-L1 Inhibitors in Non-Small-Cell Lung Cancer A Review
Adrian G. Sacher et al.
JAMA ONCOLOGY (2016)
Adverse Events Associated with Immune Checkpoint Blockade in Patients with Cancer: A Systematic Review of Case Reports
Noha Abdel-Wahab et al.
PLOS ONE (2016)
Non-small cell lung cancer: current treatment and future advances
Cecilia Zappa et al.
TRANSLATIONAL LUNG CANCER RESEARCH (2016)
Mouse models in oncoimmunology
Laurence Zitvogel et al.
NATURE REVIEWS CANCER (2016)
Towards personalized medicine: chemosensitivity assays of patient lung cancer cell spheroids in a perfused microfluidic platform
Janine Ruppen et al.
LAB ON A CHIP (2015)
High-throughput screening using patient-derived tumor xenografts to predict clinical trial drug response
Hui Gao et al.
NATURE MEDICINE (2015)
Cancer Cell Lines for Drug Discovery and Development
Jennifer L. Wilding et al.
CANCER RESEARCH (2014)
Lung Cancer Cell Lines as Tools for Biomedical Discovery and Research
Adi F. Gazdar et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2010)
Lung cancer cell lines: Useless artifacts or invaluable tools for medical science?
Adi F. Gazdar et al.
LUNG CANCER (2010)
Lung cancer therapeutics that target signaling pathways: an update
M Roshni Ray et al.
Expert Review of Respiratory Medicine (2010)
分享论文
